IL21R and benign prostatic hyperplasia: We hypothesized that IL-21R would respond to inflammatory stimuli from macrophages and play an important role in the onset and progression of BPH, via inhibiting apoptosis, modulation of cell cycle progression and the EMT process, which would provide a new molecular target for BPH therapy.